PTSD
A 2026 trial found dronabinol (synthetic THC) meaningfully cut PTSD nightmares — but overall PTSD symptoms and side-effect risks remain real concerns.
Mental Health Emerging
What the research says
PTSD is one of the most commonly self-reported reasons for medical cannabis use, and anecdotal reports are striking — many veterans and trauma survivors say it transformed their sleep and nightmares. In 2026 the strongest trial yet was published: a randomized, placebo-controlled study of dronabinol (synthetic THC, 2.5–15 mg nightly) in 171 people with PTSD found a significant reduction in nightmares — a 1.5-point drop on the nightmare severity measure versus placebo (a medium-to-large effect), with more than half of treated participants achieving at least a 50% reduction. Notably, overall PTSD symptom scores did not separate from placebo.
That's the nuance in one finding: a real, targeted effect on nightmares, but not a wholesale cure. A 2024 systematic review of cannabis and PTSD in the Journal of Clinical Psychiatry (14 studies) found no major benefits overall, though some symptom clusters improved. The same review flagged genuine risks: among people who also had cannabis-use disorder, cannabis was associated with worsening suicidal ideation and violent behavior — and the 2026 trial reported 7 serious adverse events on dronabinol versus none on placebo. There's also a real tension: cannabis can suppress REM sleep (dreaming), which may blunt nightmares — but trauma-focused therapy often relies on processing memories during sleep. Long-term cannabis use may interfere with that therapeutic work.
The honest caveats
PTSD is best treated with evidence-based therapy (CPT, PE, EMDR) plus medication under a specialist. Cannabis might help with sleep in the short term, but the evidence is not strong enough to recommend it as primary treatment — and dependence is a genuine risk. This is a 'talk to your provider' condition, not a 'pick a strain' one.
Compounds to explore
These are the compounds — terpenes and cannabinoids — that the research connects to this condition. They are starting points for reading a COA or choosing a product, not prescriptions. Each has its own guide with more detail.
Cannabinoid CBD Studied in PTSD trials, including at night for sleep and nightmares — evidence so far is mixed. Cannabinoid THC In the 2026 trial, dronabinol (synthetic THC) significantly reduced nightmares; heavy use still raises dependence risk. Terpene myrcene Sedating terpene commonly used to help with sleep in PTSD.